Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Revenue	0.02	0.03	15.23	1.06	1.57	13.11	8.81	4.07	2.84	0.43	Upgrade
Revenue Growth (YoY)	-14.81%	-99.82%	1335.16%	-32.20%	-88.06%	48.75%	116.46%	43.24%	562.47%	-75.20%	Upgrade
Gross Profit	0.02	0.03	15.23	1.06	1.57	13.11	8.81	4.07	2.84	0.43	Upgrade
Selling, General & Admin	8.58	5.11	7.02	3.69	3.79	5.6	8.53	5.76	3.84	3.42	Upgrade
Research & Development	15.56	20.17	14.54	9.49	6.48	9.77	11.14	9.89	5.94	3.33	Upgrade
Other Operating Expenses	0	0	0	0	0	0.14	0.02	0	0	0	Upgrade
Operating Expenses	24.15	25.28	21.56	13.18	10.26	15.51	19.68	15.66	9.78	6.74	Upgrade
Operating Income	-24.12	-25.26	-6.33	-12.12	-8.7	-2.4	-10.87	-11.59	-6.94	-6.31	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0	0.07	0.72	Upgrade
Other Expense / Income	-3.39	0.13	2.57	0.64	1.87	3.94	-	0.48	0.13	0.44	Upgrade
Pretax Income	-20.74	-25.38	-8.9	-12.77	-10.57	-6.34	-10.87	-12.06	-7.14	-7.47	Upgrade
Income Tax	-0.27	-0.37	-0.48	-0.3	-0.3	-0.31	-0.2	0	0	0	Upgrade
Net Income	-20.47	-25.01	-8.42	-12.47	-10.27	-6.04	-10.67	-12.06	-7.14	-7.47	Upgrade
Shares Outstanding (Basic)	163	132	95	62	48	48	43	42	17	14	Upgrade
Shares Change	23.78%	39.55%	52.17%	28.42%	0.17%	12.46%	1.56%	151.02%	21.90%	33.21%	Upgrade
EPS (Basic)	-1.12	-1.89	-0.72	-1.71	-1.79	-1.25	-0.23	-0.28	-2.99	-4.76	Upgrade
EPS (Diluted)	-1.12	-1.89	-0.72	-1.71	-1.79	-1.25	-0.23	-0.28	-2.99	-4.76	Upgrade
Free Cash Flow	-15.16	-22.76	-9.11	-8.81	-6.71	-8.66	-11.45	-12.5	-5.85	-5.74	Upgrade
Free Cash Flow Per Share	-0.93	-1.72	-0.96	-1.42	-1.39	-1.79	-2.66	-2.95	-3.47	-4.15	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-104886.96%	-93537.04%	-41.60%	-1142.60%	-555.65%	-18.32%	-123.34%	-284.60%	-244.05%	-1471.79%	Upgrade
Profit Margin	-88978.26%	-92644.44%	-55.30%	-1175.02%	-656.23%	-46.07%	-121.08%	-296.32%	-251.20%	-1740.79%	Upgrade
Free Cash Flow Margin	-65895.65%	-84303.70%	-59.83%	-830.35%	-429.01%	-66.07%	-129.90%	-307.03%	-205.81%	-1337.06%	Upgrade
EBITDA	-18.87	-23.51	-7.64	-11.68	-9.48	-4.8	-9.45	-11.42	-6.5	-6.18	Upgrade
EBITDA Margin	-82030.43%	-87085.19%	-50.17%	-1100.94%	-606.01%	-36.60%	-107.23%	-280.52%	-228.54%	-1440.79%	Upgrade
Depreciation & Amortization	1.87	1.87	1.27	1.08	1.08	1.55	1.42	0.64	0.58	0.57	Upgrade
EBIT	-20.74	-25.38	-8.9	-12.77	-10.57	-6.34	-10.87	-12.06	-7.07	-6.75	Upgrade
EBIT Margin	-90156.52%	-94007.41%	-58.48%	-1203.11%	-675.27%	-48.40%	-123.34%	-296.32%	-248.77%	-1574.13%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).